UTI Focused Fund (30 stocks) - Regular Plan - Growth Option
💡 Why Pick This Fund? Quantitative Strengths & Watch-outs
- Delivered positive returns in 100% of 3-year investment horizons.
- 5-Year CAGR of 8.77% demonstrates steady long-term compounding.
- Equities carry market risk; returns fluctuate and recommended investment horizon is 5+ years.
Key Statistics vs Category Median
Trailing Returns Comparison
| Period | Fund Return | Category Median | Difference |
|---|---|---|---|
| 1 Month | +10.68% | +7.77% | +2.91% |
| 3 Months | +2.13% | +0.86% | +1.27% |
| 6 Months | +8.64% | +7.95% | +0.69% |
| 1 Year | +1.75% | +3.65% | -1.90% |
| 3 Years CAGR | +10.80% | +12.71% | -1.91% |
| 5 Years CAGR | +8.77% | +10.23% | -1.46% |
| Since Inception | +9.54% | - | - |
📈 Monthly SIP vs Bank Fixed Deposit (FD) Replay
See how a regular monthly SIP in UTI Focused Fund 30 stocks compares against a standard 7.0% p.a. Bank Fixed Deposit.
Calendar Year Returns
| Year | Fund | Category Median | Gap |
|---|---|---|---|
| 2026 | +1.66% | +3.13% | -1.47% |
| 2025 | +6.62% | +2.93% | +3.69% |
| 2024 | +12.83% | +17.15% | -4.32% |
| 2023 | +28.85% | +28.21% | +0.64% |
| 2022 | -0.40% | -0.40% | 0.00% |
Daily Rolling Returns Summary
| Rolling Window | Minimum | Average | Median | Maximum | % Positive | % Beating Proxy |
|---|---|---|---|---|---|---|
| 1-Year Rolling | -9.91% | +11.53% | +6.61% | +43.39% | 77.3% | 28.4% |
| 3-Year Rolling | +6.60% | +13.86% | +14.27% | +20.99% | 100.0% | 14.1% |
| 5-Year Rolling | +6.49% | +7.75% | +7.65% | +9.39% | 100.0% | 0.0% |
Risk Profile & Deepest Drawdowns
Deepest Market Corrections (Depth >= 10%)
| Peak Date | Trough Date | Fall Depth | Months to Bottom | Recovery Period |
|---|---|---|---|---|
| 2024-09-26 | 2026-03-31 | -19.8% | 18 months | Not yet recovered |
| 2021-11-15 | 2022-06-17 | -18.1% | 7 months | 3 months |
Portfolio & Asset Allocation
Statutory Asset Allocation Mandate (SEBI / SID)
| Instrument Category | Permitted Allocation Range |
|---|---|
| Equity and equity related instruments (Maximum 30 stocks) | 80% -100% Money Market Instruments and other instruments permissible under residual portion: 0% - 20% |
Investment Objective & Strategy
The investment objective of the scheme is to generate long term capital appreciation by investing in equity & equity related instruments of maximum 30 stocks across market caps. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
ℹ️ Detailed monthly stock-level holdings for this scheme are updated periodically from asset management company statutory disclosures.
Fund Size Position
Currently managing Rs 2,525 cr (AMFI Daily Fund AUM as of 2026-11-11). Positioned as comfortable relative to Focused schemes.
Fund Management
Cost & Capital Gains Taxation
From April 2026 the total expense ratio includes brokerage, transaction costs and statutory levies on top of the base fee.
Equity-oriented schemes: 20% short-term capital gains tax if sold within 12 months; 12.5% long-term capital gains tax on gains exceeding ₹1.25 lakh per financial year when held for more than 12 months.
Closest Focused Peers by Rank
| Scheme | Score | 3Y Return | Expense | Downside | Fund Size | Compare |
|---|---|---|---|---|---|---|
| quant Focused Fund | 3.3 | +12.46% | 3.14% | 97.6% | Rs 864 cr | Compare → |
| Axis Focused Fund | 3.8 | +10.60% | 1.89% | 105.5% | Rs 11,120 cr | Compare → |
| Union Focused Fund | 3.9 | +12.18% | 2.55% | 82.1% | Rs 464 cr | Compare → |
| JM Focused Fund | 2.2 | +11.02% | 2.85% | 114.6% | Rs 285 cr | Compare → |
| 360 ONE Focused Fund | 4.6 | +12.28% | 2.12% | 87.8% | Rs 6,943 cr | Compare → |
Frequently Asked Questions about UTI Focused Fund 30 stocks
What is the expense ratio of UTI Focused Fund 30 stocks?
UTI Focused Fund 30 stocks has a total expense ratio (TER) of 2.22% with a base expense ratio of 1.7%, compared to the Focused category median of 2.24%.
Who manages UTI Focused Fund 30 stocks?
UTI Focused Fund 30 stocks is managed by Vishal Chopda.
What are the historical returns of UTI Focused Fund 30 stocks?
UTI Focused Fund 30 stocks delivered a 3-year CAGR of 10.8% and a 5-year CAGR of 8.77%. Its 1-year return stands at +1.75%.
How large is UTI Focused Fund 30 stocks?
UTI Focused Fund 30 stocks manages assets of Rs 2,525 cr, placing it in the 'comfortable' size band relative to Focused peers.
How is UTI Focused Fund 30 stocks scored on MFIQ?
UTI Focused Fund 30 stocks holds an MFIQ Score of 4.1/10 (Weak), based on a category percentile composite across returns, risk, consistency, and cost.
How risky is UTI Focused Fund 30 stocks?
UTI Focused Fund 30 stocks has an official SEBI riskometer rating of Very High. Over the analyzed period, its annualized standard deviation is 13.74% with a maximum historical drawdown of -19.77%.